Yüklüyor......
Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells
Objective: Currently, sorafenib is the main systemic chemotherapy drug for advanced stage of hepatocellular carcinoma (HCC). However, emerging data from some clinical HCC patients indicates that sorafenib alone has only moderate antitumor efficacy, and could not inhibit metastasis and progression of...
Kaydedildi:
| Yayımlandı: | Int J Med Sci |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ivyspring International Publisher
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6909811/ https://ncbi.nlm.nih.gov/pubmed/31839741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.37427 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|